Method for producing antibody-drug conjugate
AssigneeTakeda Pharmaceutical Company Limited
InventorsMasato SUENAGA, Kosuke TAKENAKA, Keiji IWAMOTO
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Pharmaceutical Company Limited
InventorsMasato SUENAGA, Kosuke TAKENAKA, Keiji IWAMOTO
Estimating the term…
The present invention provides a method for producing an antibody-drug conjugate (ADC) comprising an antibody and a drug linked to each other via a linker. The present invention provides a method for producing, for example, an antibody-drug conjugate (ADC) comprising an antibody and a drug linked to each other via a linker, or a pharmaceutical comprising the ADC, the method comprising mixing, using a microreactor, a solution comprising tricarboxyethyl phosphine (TCEP) and an IgG antibody under reduction reaction with TCEP, with a solution comprising a stoichiometrically excessive amount of an inhibitor of TCEP based on TCEP.
A method for producing an antibody-drug conjugate (ADC) comprising an antibody and a drug linked to each other via a linker, or a pharmaceutical comprising the ADC, the method comprising
A method for producing an antibody-drug conjugate (ADC) comprising an antibody and a drug linked to each other via a linker, or a pharmaceutical comprising the ADC, the method comprising:
A method for producing an antibody-drug conjugate (ADC) comprising an antibody and a drug linked to each other via a linker, or a pharmaceutical comprising the ADC, the method comprising:
Dependencies are inferred from the claim text.